Page 18 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 18

Contributors    xv


            Elana Ladas, PhD, RD                                  Jane A. Little, MD
            Assistant Professor of Nutrition, Columbia University, New York,   Associate Professor in Hematology/Oncology, Department of
            New York                                              Medicine, Case Western Reserve School of Medicine, Cleveland,
            Integrative Therapies in Patients with Hematologic Diseases  Ohio
                                                                  Anemia of Chronic Diseases
            Wendy Landier, PhD, CRNP
            Associate Professor, Department of Pediatrics, Division of   Jens G. Lohr, MD, PhD
            Pediatric Hematology/Oncology, Institute for Cancer Survivorship   Assistant Professor of Medicine, Harvard Medical School;
            and Outcomes, School of Medicine, University of Alabama at   Department of Medical Oncology, Dana-Farber Cancer Institute;
            Birmingham, Birmingham, Alabama                       Department of Medicine, Brigham and Women’s Hospital, Broad
            Late Complications of Hematologic Diseases and Their Therapies  Institute of MIT and Harvard, Boston, Massachusetts
                                                                  Genomic Approaches to Hematology
            Kfir Lapid, PhD
            Postdoctoral Fellow, University of Texas Southwestern, Dallas, Texas  José A. López, MD
            Interactions Between Hematopoietic Stem and Progenitor Cells and the   Chief Scientific Officer, Research Institute, Bloodworks Northwest;
            Bone Marrow: Current Biology of Stem Cell Homing and Mobilization  Professor of Medicine and Biochemistry, University of Washington,
                                                                  Seattle, Washington
            Tsvee Lapidot, PhD                                    Acquired Disorders of Platelet Function
            Professor, Incumbent of the Edith Arnoff Stein Professorial Chair
            in Stem Cell Research, Department of Immunology, Weizmann   Francis W. Luscinskas, PhD
            Institute of Science, Rehovot, Israel                 Professor of Pathology, Brigham and Women’s Hospital, Boston,
            Interactions Between Hematopoietic Stem and Progenitor Cells and the   Massachusetts
            Bone Marrow: Current Biology of Stem Cell Homing and Mobilization  Cell Adhesion
            Peter J. Larson, BS, MD                               Jaroslaw P. Maciejewski, MD, PhD
            Director, Global Clinical Strategy, Biological Products, Research   Chairman and Professor of Medicine, Department of Translational
            Triangle Park, North Carolina                         Hematology and Oncology Research, Taussig Cancer Center,
            Transfusion Therapy for Coagulation Factor Deficiencies  Cleveland Clinic, Cleveland, Ohio
                                                                  Aplastic Anemia
            Marcel Levi, MD, PhD                                  Acquired Disorders of Red Cell, White Cell, and Platelet Production
            Professor of Medicine, University College London Hospitals,
            University College London, London, United Kingdom     Navneet S. Majhail, MD, MS
            Disseminated Intravascular Coagulation                Director, Blood and Marrow Transplant Program, Cleveland Clinic;
                                                                  Professor, Cleveland Clinic Lerner College of Medicine, Cleveland,
            Russell E. Lewis, PharmD                              Ohio
            Associate Professor, Infectious Diseases, Department of Medical and   Complications After Hematopoietic Cell Transplantation
            Surgical Sciences, University of Bologna, Bologna, Italy
            Clinical Approach to Infections in the Compromised Host  Olivier Manches, PhD
                                                                  Research Assistant, Division of Hematology and Oncology, Tisch
            Howard A. Liebman, MA, MD                             Cancer Institute, Mount Sinai, New York, New York
            Professor of Medicine and Pathology, Department of Medicine,   Dendritic Cell Biology
            Hematology, Keck School of Medicine, University of Southern
            California, Los Angeles, California                   Robert J. Mandle, PhD
            Hematologic Manifestations of HIV/AIDS                President, Biosciences Research Associates, Inc., Cambridge,
                                                                  Massachusetts
            David Lillicrap, MD, FRCPC                            Complement and Immunoglobulin Biology Leading to Clinical
            Professor of Pathology and Molecular Medicine, Queen’s University,   Translation
            Kingston, Ontario, Canada
            Hemophilia A and B                                    Kenneth G. Mann, PhD
                                                                  Professor Emeritus, Biochemistry and Medicine, College of
            Wendy Lim, MD, MSc, FRCPC                             Medicine, University of Vermont, Burlington, Vermont; Chairman,
            Associate Professor of Medicine, McMaster University, Hamilton,   Haematologic Technologies Inc., Essex Junction, Vermont
            Ontario, Canada                                       Molecular Basis of Blood Coagulation
            Venous Thromboembolism
            Hematologic Manifestations of Liver Disease           Catherine S. Manno, MD
                                                                  Pat and John Rosenwald Professor and Chair, Department of
            Judith C. Lin, MD                                     Pediatrics, New York University School of Medicine, New York,
            Assistant Professor of Hematology-Oncology, Mount Sinai   New York
            Hospital, New York, New York                          Transfusion Therapy for Coagulation Factor Deficiencies
            Approach to Anemia in the Adult and Child
                                                                  Andrea N. Marcogliese, MD
            Robert Lindblad, MD, FACEP                            Associate Professor, Pathology & Immunology and Pediatrics,
            Chief Medical Officer and Director of Safety and Regulatory   Section of Hematology Oncology, Baylor College of Medicine,
            Affairs, The EMMES Corporation, Rockville, Maryland   Houston, Texas
            Investigational New Drug–Enabling Processes for Cell-Based Therapies  Resources for the Hematologist: Interpretive Comments and Selected
                                                                  Reference Values for Neonatal, Pediatric, and Adult Populations
            Gregory Y.H. Lip, MD, FRCP, FACC, FESC
            Professor of Cardiovascular Medicine, Institute of Cardiovascular   Guglielmo Mariani, MD
            Sciences, University of Birmingham, Birmingham, United Kingdom  Faculty of Science and Technology, University of Westminster,
            Atrial Fibrillation                                   London, United Kingdom
                                                                  Inhibitors in Hemophilias
   13   14   15   16   17   18   19   20   21   22   23